Mahoney David L sells $12.3M of CORTMahoney David L 内部减持 Corcept医疗 (CORT) $12.3M
Insider Sale Event Details
Corcept Therapeutics (CORT) director MAHONEY DAVID L executed open-market sales of 103,606 CORT common shares on August 18, 2026, for total proceeds of $12,251,411 at an average price of $118.25 per share. A corresponding Form 4 ownership disclosure filing was submitted to the U.S. SEC on August 20, 2026. The total sale value equals 0.094% of CORT’s $13.1B current market capitalization, making this a material director-level position change for market participants to track.
Transaction Breakdown and Signal Context
The sale was disclosed as four combined trades in the August 20 Form 4 filing: 4,984 shares at $117.47 ($585,478), 91,167 shares at $118.24 ($10,779,367), 7,055 shares at $118.88 ($838,710), and 400 shares at $119.64 ($47,855). Compared to recent insider activity on August 18, two other directors completed smaller open-market sales, but MAHONEY’s total sale value was the largest director sell transaction in that period.
Cross-Referenced Independent Signal
A verified independent market signal includes the December 31, 2025 13F institutional holding summary: CORT had 416 institutional holders, with aggregate holdings of $4.1B representing 74.0% of the company’s floating stock. Separately, an August 16, 2026 public disclosure noted Handelsbanken Fonder AB increased its CORT holdings, creating a contrasting institutional flow signal to this insider sale.
Signal Limitations and Follow-Up Markers
This Form 4 filing only documents the executed open-market sale, and does not confirm the seller’s motivation, whether the trade was part of a pre-arranged 10b5-1 plan, or reflect a view on the company’s future performance or valuation. Follow-up items to monitor include CORT’s Q3 2026 earnings report scheduled for November 3, 2026, subsequent insider trading disclosures, and updated institutional holding data.
本次内部人减持事件
科塞普治疗公司（CORT）董事MAHONEY DAVID L于2026年8月18日通过公开市场卖出103,606股CORT普通股，交易总价值12,251,411美元，每股均价约118.25美元。相关Form 4所有权披露文件于2026年8月20日提交至美国SEC。本次减持价值占CORT当前131亿美元市值的0.094%，属于董事级别持仓变动中规模较大的一笔。
交易规模与信号解读
本次减持并非单笔交易，而是四笔合并披露的公开市场卖出：4,984股（均价117.47美元，价值585,478美元）、91,167股（均价118.24美元，价值10,779,367美元）、7,055股（均价118.88美元，价值838,710美元）及400股（均价119.64美元，价值47,855美元）。对比近期其他内部交易，8月18日另有两名董事完成小额减持，但MAHONEY本次的总交易价值为同期最大的董事卖出操作。
交叉验证独立信号
可参考的合规独立市场信号包括：截至2025年12月31日的13F机构持仓摘要显示，CORT共有416家机构持有者，合计持有74.0%的流通股，总持仓价值41亿美元；2026年8月16日另有公开披露显示Handelsbanken Fonder AB增持CORT股票，与本次内部人减持形成反向的机构持仓变动信号。
信号局限与后续关注
本次Form 4披露仅记录了公开市场减持的事实，无法推断MAHONEY的交易动机、是否采用10b5-1预先安排交易计划，也不代表对公司未来业绩或估值的判断。后续需关注CORT 2026年11月3日发布的三季度财报、后续内部人交易披露及机构持仓的最新变动。
This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考，不构成投资建议。